|
|
Volumn 17, Issue 3, 1995, Pages 425-432
|
|
Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GANCICLOVIR;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
BIOAVAILABILITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
CYTOMEGALOVIRUS INFECTION;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, ORAL;
ADULT;
ANTIVIRAL AGENTS;
BIOLOGICAL AVAILABILITY;
CROSS-OVER STUDIES;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
GANCICLOVIR;
HIV SEROPOSITIVITY;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
|
|
EID: 0029151391
PISSN: 01492918
EISSN: None
Source Type: Journal
DOI: 10.1016/0149-2918(95)80107-3 Document Type: Article |
|
Times cited : (86)
|
|
References (9)
|
